Skip to main content

Table 1 Association of RHBDD1 expression with clinicopathologic parameters of NSCLC patients

From: Silibinin suppresses epithelial–mesenchymal transition in human non-small cell lung cancer cells by restraining RHBDD1

Clinical pathologic parameters Total (n = 56) Expression of RHBDD1 p-value
High (n = 35) Low (n = 21) (chi-square test)
Sex     0.0937
 Male 37 26 11  
 Female 19 9 10  
Age     0.5343
 < 60 27 18 9  
 ≥ 60 29 17 12  
Tumor size (cm)     0.2035
 < 4 22 16 6  
 ≥ 4 34 19 15  
TNM stage     0.0008
 I + II 35 16 19  
 III + IV 21 19 2  
Lymph node metastasis     0.0006
 Yes 37 29 8  
 No 19 6 13  
  1. Note: The bold values indicates the P values which are less than 0.05
  2. Abbreviations: NSCLC Non-small cell lung cancer, TNM Tumor-node-metastasis classification system